HOW CANADIANS VALUE RARE DISEASES GIVEN THEIR OPPORTUNITY COST?

被引：1
|
作者：
Rizzardo, S. [1 ]
Bansback, N. [1 ]
Mitton, C. [1 ]
Marra, C. [1 ]
Lynd, L. [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.027
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PP3
引用
收藏
页码：A4 / A4
页数：1
相关论文
共 50 条
  • [1] OPPORTUNITY COST AND REPLACEMENT VALUE
    UITERMARK, PJ
    ECONOMIST, 1969, 117 (05): : 433 - 492
  • [2] Opportunity Cost of Funding Drugs for Rare Diseases: The Cost-Effectiveness of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
    Coyle, Doug
    Cheung, Matthew C.
    Evans, Gerald A.
    MEDICAL DECISION MAKING, 2014, 34 (08) : 1016 - 1029
  • [3] SCREENING FOR HYPERCHOLESTEROLEMIA AMONG CANADIANS - HOW MUCH WILL IT COST
    GROVER, SA
    COUPAL, L
    FAHKRY, R
    SUISSA, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1991, 144 (02) : 161 - 168
  • [4] CHALLENGES IN COST-EFFECTIVENESS MODELLING AND VALUE ASSESSMENT OF TREATMENTS IN RARE DISEASES
    Teitsson, S.
    von, Hein M.
    VALUE IN HEALTH, 2020, 23 : S338 - S339
  • [5] The National Plan for rare diseases, an opportunity for patients
    Guillevin, Loic
    PRESSE MEDICALE, 2008, 37 (01): : 3 - 5
  • [6] Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives
    Harris, Emily
    JOURNAL OF LAW AND THE BIOSCIENCES, 2018, 5 (03): : 648 - 681
  • [7] An opportunity cost model to value deferral options
    Kim, Gyutai
    Miller, Luke
    Baek, Jung Woo
    ENGINEERING ECONOMIST, 2024, 69 (02): : 88 - 107
  • [8] RARE OPPORTUNITY How SRC Meeting the challenge
    Imran, Muhammad
    Gotto, Rebecca
    Canadian Mining Journal, 2022, 143 (04) : 32 - 34
  • [9] How many rare diseases are there?
    Haendel, Melissa
    Vasilevsky, Nicole
    Unni, Deepak
    Bologa, Cristian
    Harris, Nomi
    Rehm, Heidi
    Hamosh, Ada
    Baynam, Gareth
    Groza, Tudor
    McMurry, Julie
    Dawkins, Hugh
    Rath, Ana
    Thaxon, Courtney
    Bocci, Giovanni
    Joachimiak, Marcin P.
    Koehler, Sebastian
    Robinson, Peter N.
    Mungall, Chris
    Oprea, Tudor I.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (02) : 77 - 78
  • [10] Brexit and rare diseases: big risk, bigger opportunity?
    Hyry, Hanna I.
    Cox, Timothy M.
    Roos, Jonathan C. P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 783 - +
12345